We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+7.33%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.44B
AUM Growth
+$259M
(+4.2%)
Cap. Flow
+$227M
Cap. Flow
% of AUM
3.52%
Top 10 Holdings %
Top 10 Hldgs %
34.31%
Holding
1,318
New
461
Increased
339
Reduced
236
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$330M |
| 2 |
Brookdale Senior Living
BKD
|
+$93.7M |
| 3 |
Tenet Healthcare
THC
|
+$85.2M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$70.6M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$206M |
| 2 |
CVS Health
CVS
|
+$122M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$102M |
| 4 |
McKesson
MCK
|
+$80.6M |
| 5 |
Pacira BioSciences
PCRX
|
+$45.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.08% |
| 2 | Miscellaneous | 9.89% |
| 3 | Energy | 6.47% |
| 4 | Consumer Discretionary | 5.67% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Ashland
ASH
$3.22B
| $12.2M | 0.19% |
229,533
+57,745
| +34% | +$2.88M |
|
102
Universal Health Services
UHS
$10.4B
| $12.2M | 0.19% |
+126,999
| New | +$11M |
|
103
LyondellBasell Industries
LYB
$21.1B
| $12.1M | 0.19% |
123,923
-76,409
| -38% | -$7.28M |
|
|
ABAX
104
DELISTED
Abaxis Inc
ABAX
| $12.1M | 0.19% |
272,140
+22,140
| +9% | +$921K |
|
105
Elevance Health
ELV
$90.6B
| $12.1M | 0.19% |
112,039
+27,593
| +33% | +$2.84M |
|
106
Skyworks Solutions
SWKS
$13.5B
| $11.8M | 0.18% |
251,906
+27,266
| +12% | +$1.15M |
|
|
ITCI
107
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $11.8M | 0.18% |
700,479
| – | – |
|
|
108
Bausch Health
BHC
$2.12B
| $11.8M | 0.18% |
93,427
-1,618,300
| -95% | -$206M |
|
|
NRF
109
DELISTED
NorthStar Realty Finance Corp.
NRF
| $11.8M | 0.18% |
345,184
+235,220
| +214% | +$7.41M |
|
110
SunCoke Energy
SXC
$803M
| $11.8M | 0.18% |
547,174
+90,778
| +20% | +$1.91M |
|
|
RCPT
111
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $11.8M | 0.18% |
276,030
+124,732
| +82% | +$4.31M |
|
|
RFMD
112
DELISTED
RF MICRO DEVICES INC
RFMD
| $11.6M | 0.18% |
1,210,000
+170,145
| +16% | +$1.51M |
|
113
Stryker
SYK
$108B
| $11.5M | 0.18% |
+136,355
| New | +$11.1M |
|
|
YHOO
114
DELISTED
Yahoo Inc
YHOO
| $11.5M | 0.18% |
326,984
-79,614
| -20% | -$2.78M |
|
115
W.R. Berkley
WRB
$26.5B
| $11.4M | 0.18% |
+830,797
| New | +$10.8M |
|
116
Southern Copper
SCCO
$160B
| $11.3M | 0.18% |
407,876
-165,463
| -29% | -$4.5M |
|
117
Teleflex
TFX
$5.47B
| $11.2M | 0.17% |
106,327
+9,482
| +10% | +$995K |
|
|
ZGNX
118
DELISTED
Zogenix, Inc.
ZGNX
| $10.9M | 0.17% |
676,625
-10,875
| -2% | -$196K |
|
119
Entergy
ETR
$49.2B
| $10.8M | 0.17% |
263,850
+251,754
| +2,081% | +$9.39M |
|
|
PX
120
DELISTED
Praxair Inc
PX
| $10.8M | 0.17% |
80,990
+79,343
| +4,817% | +$10.4M |
|
121
Truist Financial
TFC
$61.6B
| $10.7M | 0.17% |
272,190
+89,095
| +49% | +$3.42M |
|
|
JNPR
122
DELISTED
Juniper Networks
JNPR
| $10.7M | 0.17% |
434,936
-46,961
| -10% | -$1.17M |
|
|
GNMK
123
DELISTED
GenMark Diagnostics, Inc
GNMK
| $10.6M | 0.17% |
786,468
-179,067
| -19% | -$1.87M |
|
|
LITS
124
Lite Strategy Inc
LITS
$37.1M
| $10.5M | 0.16% |
83,031
| – | – |
|
125
Prudential Financial
PRU
$41.2B
| $10.5M | 0.16% |
118,524
+86,056
| +265% | +$7.24M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Visium Asset Management held 1,318 positions worth $6.44B, up 4.2% from $6.18B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Visium Asset Management deployed $227M of net new capital in Q2 2014, opening 461 new positions and adding to 339 existing holdings. Its largest new stake was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 56% a quarter earlier, followed by Miscellaneous and Energy.
On the sell side, the largest reduction was Bausch Health, an estimated $206M trimmed.
- Visium Asset Management's largest Q2 2014 buy was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
- Visium Asset Management added most to Allergan Inc in Q2 2014, an estimated $330M increase.
- Visium Asset Management's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $206M.
- Visium Asset Management fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $34M.
- Visium Asset Management's ten largest holdings make up 34% of its $6.44B portfolio in Q2 2014.
- Visium Asset Management opened 461 new positions and closed 232 in Q2 2014.
- Visium Asset Management's portfolio value rose 4.2% quarter-over-quarter to $6.44B.
Based on Visium Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.